National Institutes of Health
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing January 7, 2028.
Jan 7, 2028
(525d left)